SCHEMBL22908274

SCHEMBL22908274

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cccc5c4Sc4ccccc4C54c5ccccc5-c5ccccc54)cc3)n2)cc1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.33
ADORA3 P0DMS8 2/20 0.33
ADORA2A P29274 2/20 0.33
ADORA2B P29275 2/20 0.33
ADORA1 P30542 2/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
MEN1 O00255 3/20 0.33
MAPT P10636 3/20 0.33
KMT2A Q03164 3/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
KDM4E B2RXH2 2/20 0.32
LMNA P02545 2/20 0.32
GLA P06280 1/20 0.32
GPR55 Q9Y2T6 1/20 0.32
OPRK1 P41145 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23814913 0.99 L3MBTL1 (0.33) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL21658269 0.99 L3MBTL1 (0.33) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL21658271 0.99 L3MBTL1 (0.33) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL23814866 0.96 ADORA3 (0.33) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL23814391 0.96 ADORA3 (0.33) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL23814918 0.95 GPR55 (0.33) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL21658432 0.94 PDK2 (0.33) MEN1MAPTKMT2AALDH1A1HPGD
SCHEMBL23814390 0.94 PDK2 (0.33) MEN1MAPTKMT2AALDH1A1HPGD
SCHEMBL23814697 0.94 PDK2 (0.33) MEN1MAPTKMT2AALDH1A1HPGD
SCHEMBL21658434 0.93 ALOX15 (0.35) L3MBTL1ADORA3ADORA2AADORA2BADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024114-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2023-01-26 US disclosed
US-20230006161-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2023-01-05 US disclosed
US-20210288260-A1 ORGANIC LIGHT EMITTING DIODE LG CHEM, LTD. (KR) 2021-09-16 US disclosed
US-20210143344-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2021-05-13 US disclosed
US-20210020842-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2021-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210020842-A1 ORGANIC LIGHT-EMITTING DEVICE OR10J3, OR51E2, LOXL1 L3MBTL1 747/4885ADORA3 4367/4885ADORA2A 4182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.